docetaxel anhydrous has been researched along with stattic in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (stattic) | Trials (stattic) | Recent Studies (post-2010) (stattic) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 142 | 0 | 130 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | stattic (IC50) |
|---|---|---|---|
| Signal transducer and activator of transcription 3 | Homo sapiens (human) | 5.1 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 0.043 | |
| Thioredoxin glutathione reductase | Schistosoma mansoni | 2.01 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrys, R; Balintova, S; Hodny, Z; Malinak, D; Mikyskova, R; Musilek, K; Novotny, O; Psotka, M; Reinis, M; Rysanek, D; Sapega, O; Svobodova, J | 1 |
1 other study(ies) available for docetaxel anhydrous and stattic
| Article | Year |
|---|---|
STAT3 inhibitor Stattic and its analogues inhibit STAT3 phosphorylation and modulate cytokine secretion in senescent tumour cells.
Topics: Animals; Cellular Senescence; Cytokines; Docetaxel; Gene Expression; Mice; Phosphorylation; STAT3 Transcription Factor | 2023 |